Nurix Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Nurix Therapeutics Inc
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
/ 
Frequently asked questions
To buy Nurix Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Nurix Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Nurix Therapeutics Inc is NRIX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Nurix Therapeutics Inc has its primary listing on NASDAQ. You can trade Nurix Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Nurix Therapeutics Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Nurix Therapeutics Inc as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Nurix Therapeutics Inc.